Pharmacy preparations and compounding.
作者信息
van der Schors Tjalling, Amann Steffen, Makridaki Despoina, Kohl Stephanie
机构信息
Hospital Pharmacy, Dijklander Ziekenhuis, Hoorn, The Netherlands.
Krankenhausapotheke (Hospital Pharmacy), München Klinik gGmbH, Munich, Germany.
出版信息
Eur J Hosp Pharm. 2021 Jul;28(4):190-192. doi: 10.1136/ejhpharm-2020-002559. Epub 2020 Nov 25.
Abstract
摘要
相似文献
1
Pharmacy preparations and compounding.药剂制备与调配
Eur J Hosp Pharm. 2021 Jul;28(4):190-192. doi: 10.1136/ejhpharm-2020-002559. Epub 2020 Nov 25.
2
Compounding practices in Iran.伊朗的配药实践。
Int J Pharm Compd. 2014 Mar-Apr;18(2):112-6.
3
Summary of Educational Offerings Provided by Compounding Support Companies in 2019.2019年由复方制剂支持公司提供的教育课程总结。
Int J Pharm Compd. 2019 May-Jun;23(3):188-191.
4
Independent community pharmacists' perspectives on compounding in contemporary pharmacy education.独立社区药剂师对当代药学教育中药物配制的看法。
Am J Pharm Educ. 2009 May 27;73(3):54. doi: 10.5688/aj730354.
5
Editorial: Should All Pharmacists Compound?社论：是否所有药师都应该调配药物？
Int J Pharm Compd. 2022 Jan-Feb;26(1):24-28.
6
ASHP statement on hospital drug control systems.美国卫生系统药师协会关于医院药品控制系统的声明。
Am J Hosp Pharm. 1974 Dec;31(12):1198-207.
7
Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.约旦药店临时配制的流行情况、决定因素和特征。
BMC Health Serv Res. 2019 Nov 8;19(1):816. doi: 10.1186/s12913-019-4684-y.
8
American hospital pharmacy from the Colonial period to the 1930s.
Am J Hosp Pharm. 1994 Nov 15;51(22):2817-23.
9
[Medicine compounding in the pharmacy].[药房中的药物调配]
Ned Tijdschr Geneeskd. 2023 Mar 16;167:D6806.
10
ASHP national survey of pharmacy practice in hospital settings: Dispensing and administration-2017.美国卫生系统药师协会医院药房实践全国性调查：调配与给药 - 2017年
Am J Health Syst Pharm. 2018 Aug 15;75(16):1203-1226. doi: 10.2146/ajhp180151. Epub 2018 Jun 14.
引用本文的文献
1
AmBisome Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies.儿科用两性霉素B脂质体配方：稳定性、细胞毒性及成本效益研究
Pharmaceutics. 2024 Mar 27;16(4):466. doi: 10.3390/pharmaceutics16040466.
2
Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022.2017年至2022年间美国食品药品监督管理局（FDA）发给混合调配药房的关于违反现行药品生产质量管理规范的警告信内容分析
J Pharm Innov. 2022 Nov 16:1-15. doi: 10.1007/s12247-022-09692-4.
本文引用的文献
1
Improvement of Chemotherapy Solutions Production Procedure in a Hospital Central Chemotherapy Preparation Unit: A Systematic Risk Assessment to Prevent Avoidable Harm in Cancer Patients.医院中央化疗制剂室化疗溶液生产流程的改进：预防癌症患者可避免伤害的系统风险评估
Clin Med Insights Oncol. 2019 Jun 10;13:1179554919852933. doi: 10.1177/1179554919852933. eCollection 2019.
2
Impact of the Council of Europe Resolution on quality and safety assurance requirements for medicinal products prepared in pharmacies for the special needs of patients.欧洲委员会决议对药房为满足患者特殊需求而制备的药品质量和安全保证要求的影响。
Eur J Hosp Pharm. 2017 Jul;24(4):218-223. doi: 10.1136/ejhpharm-2016-001017. Epub 2016 Sep 5.
3
Paediatric and geriatric drug delivery.儿科与老年药物递送
Expert Opin Drug Deliv. 2007 Jan;4(1):37-45. doi: 10.1517/17425247.4.1.37.
Zotero 插件